Literature DB >> 33634038

Innate Immune Responses of Galleria mellonella to Mycobacterium bovis BCG Challenge Identified Using Proteomic and Molecular Approaches.

Masanori Asai1, Gerard Sheehan2,3, Yanwen Li1, Brian D Robertson4, Kevin Kavanagh2, Paul R Langford1, Sandra M Newton1.   

Abstract

The larvae of the insect Galleria mellonella, have recently been established as a non-mammalian infection model for the Mycobacterium tuberculosis complex (MTBC). To gain further insight into the potential of this model, we applied proteomic (label-free quantification) and transcriptomic (gene expression) approaches to characterise the innate immune response of G. mellonella to infection with Mycobacterium bovis BCG lux over a 168 h time course. Proteomic analysis of the haemolymph from infected larvae revealed distinct changes in the proteome at all time points (4, 48, 168 h). Reverse transcriptase quantitative PCR confirmed induction of five genes (gloverin, cecropin, IMPI, hemolin, and Hdd11), which encoded proteins found to be differentially abundant from the proteomic analysis. However, the trend between gene expression and protein abundance were largely inconsistent (20%). Overall, the data are in agreement with previous phenotypic observations such as haemocyte internalization of mycobacterial bacilli (hemolin/β-actin), formation of granuloma-like structures (Hdd11), and melanization (phenoloxidase activating enzyme 3 and serpins). Furthermore, similarities in immune expression in G. mellonella, mouse, zebrafish and in vitro cell-line models of tuberculosis infection were also identified for the mechanism of phagocytosis (β-actin). Cecropins (antimicrobial peptides), which share the same α-helical motif as a highly potent peptide expressed in humans (h-CAP-18), were induced in G. mellonella in response to infection, giving insight into a potential starting point for novel antimycobacterial agents. We believe that these novel insights into the innate immune response further contribute to the validation of this cost-effective and ethically acceptable insect model to study members of the MTBC.
Copyright © 2021 Asai, Sheehan, Li, Robertson, Kavanagh, Langford and Newton.

Entities:  

Keywords:  Galleria mellonella; Mycobacterium bovis BCG; gene expression; in vivo model; innate immunity; proteomics; tuberculosis

Year:  2021        PMID: 33634038      PMCID: PMC7900627          DOI: 10.3389/fcimb.2021.619981

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  83 in total

Review 1.  Animal Models for Tuberculosis in Translational and Precision Medicine.

Authors:  Lingjun Zhan; Jun Tang; Mengmeng Sun; Chuan Qin
Journal:  Front Microbiol       Date:  2017-05-04       Impact factor: 5.640

2.  The insect metalloproteinase inhibitor gene of the lepidopteran Galleria mellonella encodes two distinct inhibitors.

Authors:  Marianne Wedde; Christoph Weise; Rolf Nuck; Boran Altincicek; Andreas Vilcinskas
Journal:  Biol Chem       Date:  2007-01       Impact factor: 3.915

Review 3.  Insect inhibitors of metalloproteinases.

Authors:  Andreas Vilcinskas; Marianne Wedde
Journal:  IUBMB Life       Date:  2002-12       Impact factor: 3.885

4.  Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis.

Authors:  Devinder Kaur; Patrick J Brennan; Dean C Crick
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

5.  Galleria mellonella native and analogue peptides Gm1 and ΔGm1. I) biophysical characterization of the interaction mechanisms with bacterial model membranes.

Authors:  Wilmar Correa; Marcela Manrique-Moreno; Edwin Patiño; Carlos Peláez-Jaramillo; Yani Kaconis; Thomas Gutsmann; Patrick Garidel; Lena Heinbockel; Klaus Brandenburg
Journal:  Biochim Biophys Acta       Date:  2014-07-10

6.  Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments.

Authors:  Frances M Entwistle; Peter J Coote
Journal:  J Med Microbiol       Date:  2018-02-13       Impact factor: 2.472

Review 7.  Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction.

Authors:  Arun K Mishra; Nicole N Driessen; Ben J Appelmelk; Gurdyal S Besra
Journal:  FEMS Microbiol Rev       Date:  2011-05-31       Impact factor: 16.408

8.  Analysis of the early cellular and humoral responses of Galleria mellonella larvae to infection by Candida albicans.

Authors:  Gerard Sheehan; Kevin Kavanagh
Journal:  Virulence       Date:  2017-09-21       Impact factor: 5.882

9.  Immuno-physiological adaptations confer wax moth Galleria mellonella resistance to Bacillus thuringiensis.

Authors:  Ivan M Dubovskiy; Ekaterina V Grizanova; Miranda M A Whitten; Krishnendu Mukherjee; Carolyn Greig; Tatiana Alikina; Marsel Kabilov; Andreas Vilcinskas; Viktor V Glupov; Tariq M Butt
Journal:  Virulence       Date:  2016-03-30       Impact factor: 5.882

10.  Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae.

Authors:  Gerard Sheehan; Mickey Konings; Wilson Lim; Ahmed Fahal; Kevin Kavanagh; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2020-04-08
View more
  2 in total

1.  Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella.

Authors:  Victor Garcia-Bustos; Javier Pemán; Alba Ruiz-Gaitán; Marta Dafne Cabañero-Navalon; Ana Cabanilles-Boronat; María Fernández-Calduch; Lucía Marcilla-Barreda; Ignacio A Sigona-Giangreco; Miguel Salavert; María Ángeles Tormo-Mas; Amparo Ruiz-Saurí
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

2.  Galleria mellonella as an infection model for the virulent Mycobacterium tuberculosis H37Rv.

Authors:  Masanori Asai; Yanwen Li; John Spiropoulos; William Cooley; David J Everest; Sharon L Kendall; Carlos Martín; Brian D Robertson; Paul R Langford; Sandra M Newton
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.